Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (36)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Siebert, R.
Right arrow Articles by Schlegelberger, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Siebert, R.
Right arrow Articles by Schlegelberger, B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 9:519-526, 1998
© 1998 European Society for Medical Oncology


research-article

Application of interphase cytogenetics for the detection of t(11;14)(ql3;q32) in mantle cell lymphomas

R. Siebert1, P. Matthiesen1, S. Harder1, Y. Zhang1, A. Borowski1, R. Zühlke-Jenisch1, H. Plendl1, S. Metzke1, S. Joos2, E. Zucca3, K. Weber-Matthiesen1, E. Roggero3, W. Grote1 and B. Schlegelberger1,

1Department of Human Genetics, University of Kiel Kiel
2Deutsches Krebsforschungszentrum Heidelberg, Germany
3Division of Oncology, Ospedale San Giovanni Bellinzona, Switzerland

Correspondence to: Prof. Dr. med. B. Schlegelberger Department of Human Genetics University of Kiel, Schwanenweg 24, 24105 Kiel, Germany. E-mail: office@medgen.uni-kiel.de

BACKGROUND: The chromosomal translocation t(11;14)(q13;q32) is the hallmark of mantle cell lymphoma (MCL) in which it can be detected cytogenetically in about 75% of cases. The t(11;14) translocation juxtaposes the bcl-1 locus in chromosome band 11q13 next to the IgH locus in chromosome band 14q32 and, thus, leads to deregulation of the cell cycle regulatory protein cyclin D1, which is encoded by the CCND1 gene localized at the telomeric border of the bcl-1-locus. MCL has the worst prognosis of all low-grade non-Hodgkin's lymphomas (NHL). In some instances, however, histopathologic differentiation between MCL and other low-grade B-cell NHL is difficult. Therefore, detection of the t(11;14) translocation is of essential diagnostic value for the risk-adjusted management of patients with MCL. Unfortunately, chromosome analyses are frequently hampered by the low yield and quality of tumor metaphases. As the 11q13 breakpoints are scattered over a region of more than 120 kb the application of molecular genetic techniques is also limited.

PATIENTS AND METHODS: We established an interphase fluorescence in situ hybridization (FISH) approach for the detection of the t(11;14) translocation by use of a cosmid probe hybridizing to the IgH constant region and a YAC spanning the bcl-1 region. Cells containing a t(11;14) translocation show a co-localisation of the signals for IgH and bcl--1 Eight control samples and 15 MCL specimens were investigated.

RESULTS: According to our control studies, samples containing more than 10% of cells with this signal constellation can be diagnosed as carrying a clonal t(11;14) translocation. All eleven MCL found to carry the t(11; 14) translocation by chromosome analysis were positive in our FISH assay. Additionally, two of four MCL lacking a clonal t(11;14) translocation by chromosome analysis were shown to carry this aberration in 14% and 37% of interphase nuclei. Southern blot data indicate that our FISH assay reliably detects the t(11;14) translocation irrespective of the location of the breakpoints within the bcl-1 region.

CONCLUSIONS: The described interphase FISH assay provides a reliable and routinely applicable tool for diagnosis of the t(11;14) translocation.

cytogenetics, fluorescence in situ hybridization, mantle-cell lymphoma, translocation t(11;14)


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
BloodHome page
A. Hachem and R. B. Gartenhaus
Oncogenes as molecular targets in lymphoma
Blood, September 15, 2005; 106(6): 1911 - 1923.
[Full Text] [PDF]


Home page
JCOHome page
T. E. Witzig
Current Treatment Approaches for Mantle-Cell Lymphoma
J. Clin. Oncol., September 10, 2005; 23(26): 6409 - 6414.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. A. Martinez-Climent, E. Vizcarra, D. Sanchez, D. Blesa, I. Marugan, I. Benet, F. Sole, F. Rubio-Moscardo, M. J. Terol, J. Climent, et al.
Loss of a novel tumor suppressor gene locus at chromosome 8p is associated with leukemic mantle cell lymphoma
Blood, December 1, 2001; 98(12): 3479 - 3482.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Schlegelberger, T. Zwingers, L. Harder, H. Nowotny, R. Siebert, M. Vesely, H. Bartels, R. Sonnen, G. Hopfinger, A. Nader, et al.
Clinicopathogenetic Significance of Chromosomal Abnormalities in Patients With Blastic Peripheral B-Cell Lymphoma
Blood, November 1, 1999; 94(9): 3114 - 3120.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J.-Y. Li, F. Gaillard, A. Moreau, J.-L. Harousseau, C. Laboisse, N. Milpied, R. Bataille, and H. Avet-Loiseau
Detection of Translocation t(11;14)(q13;q32) in Mantle Cell Lymphoma by Fluorescence in Situ Hybridization
Am. J. Pathol., May 1, 1999; 154(5): 1449 - 1452.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Cuneo, R. Bigoni, G. M. Rigolin, M. G. Roberti, A. Bardi, N. Piva, R. Milani, F. Bullrich, M. L. Veronese, C. Croce, et al.
Cytogenetic Profile of Lymphoma of Follicle Mantle Lineage: Correlation With Clinicobiologic Features
Blood, February 15, 1999; 93(4): 1372 - 1380.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.